Terms: = Gastric cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
2825 results:
1. Helicobacter pylori treatment and gastric cancer Risk Among Individuals With High Genetic Risk for gastric cancer.
Xu HM; Han Y; Liu ZC; Yin ZY; Wang MY; Yu C; Ma JL; Sun D; Liu WD; Zhang Y; Zhou T; Zhang JY; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Chen Z; You WC; Li L; Pan KF; Lv J; Li WQ
JAMA Netw Open; 2024 May; 7(5):e2413708. PubMed ID: 38809553
[TBL] [Abstract] [Full Text] [Related]
2. HCA-DAN: hierarchical class-aware domain adaptive network for gastric tumor segmentation in 3D CT images.
Yuan N; Zhang Y; Lv K; Liu Y; Yang A; Hu P; Yu H; Han X; Guo X; Li J; Wang T; Lei B; Ma G
Cancer Imaging; 2024 May; 24(1):63. PubMed ID: 38773670
[TBL] [Abstract] [Full Text] [Related]
3. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines.
Saeedi F; Salehi M; Kamali MJ; Mir MA; Kazemi S; Shirafkan F; Neyshaburi EZ; Moeeni R; Gorji N; Memariani Z
Med Oncol; 2024 May; 41(6):148. PubMed ID: 38733486
[TBL] [Abstract] [Full Text] [Related]
5. Contemporary outcomes for resected type 1-3 gastroesophageal junction adenocarcinoma: a single-center experience.
Stiles ZE; Hagerty BL; Brady M; Mukherjee S; Hochwald SN; Kukar M
J Gastrointest Surg; 2024 May; 28(5):634-639. PubMed ID: 38704200
[TBL] [Abstract] [Full Text] [Related]
6. Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials.
Khan A; Khan H; Hughes GK; Ladd C; McIntire R; Gardner B; Peña AM; Schoutko A; Tuia J; Minley K; Haslam A; Prasad V; Vassar M
Cancer Med; 2024 May; 13(9):e7130. PubMed ID: 38698690
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Yan Y; Wu D; Wang W; Lv Y; Yang L; Liu Y; Dong P; Yu X
J Cancer Res Ther; 2024 Apr; 20(2):633-641. PubMed ID: 38687934
[TBL] [Abstract] [Full Text] [Related]
8. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract] [Full Text] [Related]
9. Management of malignant gastric Outlet Obstruction (mGOO) due to pancreatic cancer in the era of EUS-Gastrojejunostomy: an international practice survey and case vignette study by Pancreas 2000 from the European Pancreatic Club.
De Ponthaud C; Bozkirli B; Rizzo GEM; Robinson S; Vilas-Boas F; Capurso G; Gaujoux S; Vanella G
Surg Endosc; 2024 Jun; 38(6):3231-3240. PubMed ID: 38649494
[TBL] [Abstract] [Full Text] [Related]
10. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
11. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
12. Challenging the Dogma: Stage migration or negative lymph nodes, which of them is the main player on gastric cancer prognosis?
Costa PMD; Antunes C; Lages P; Rodrigues J; Peyroteo M; Onofre S; Lara Santos L
Eur J Surg Oncol; 2024 Jun; 50(6):108318. PubMed ID: 38626587
[TBL] [Abstract] [Full Text] [Related]
13. The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies-experience from a tertiary care center in Germany.
Reese M; Eichelmann AK; Nowacki TM; Pascher A; Sporn JC
Langenbecks Arch Surg; 2024 Apr; 409(1):113. PubMed ID: 38589714
[TBL] [Abstract] [Full Text] [Related]
14. Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapy.
Gal O; Lewin R; Perl G; Ulitzky O; Brenner B; Kundel Y
J Cancer Res Ther; 2024 Jan; 20(1):281-284. PubMed ID: 38554334
[TBL] [Abstract] [Full Text] [Related]
15. Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis.
Eskandarion MR; Eskandarieh S; Tutunchi S; Shakoori Farahani A; Shirkoohi R
Clin Exp Med; 2024 Mar; 24(1):59. PubMed ID: 38554188
[TBL] [Abstract] [Full Text] [Related]
16. A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.
Shi JM; Li N; Jiang LM; Yang L; Wang SL; Song YW; Liu YP; Fang H; Lu NN; Qi SN; Chen B; Li YX; Zhao DB; Tang Y; Jin J
Sci Rep; 2024 Mar; 14(1):7522. PubMed ID: 38553594
[TBL] [Abstract] [Full Text] [Related]
17. [Incidence of postoperative complications in Chinese patients with gastric or colorectal cancer based on a national, multicenter, prospective, cohort study].
Zhang SQ; Wu ZQ; Huo BW; Xu HN; Zhao K; Jing CQ; Liu FL; Yu J; Li ZR; Zhang J; Zang L; Hao HK; Zheng CH; Li Y; Fan L; Huang H; Liang P; Wu B; Zhu JM; Niu ZJ; Zhu LH; Song W; You J; Yan S; Li ZY
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):247-260. PubMed ID: 38532587
[No Abstract] [Full Text] [Related]
18. Long-term outcomes of endoscopic therapy versus surgical resection for 2-5 cm gastric gastrointestinal stromal tumors: A population-based comparative study.
Chai Y; Lin B; Zhong J; Wu X; Lin X; Ge X; Jiang J; Liang Z; Liu S; Gu C
Eur J Surg Oncol; 2024 Jun; 50(6):108262. PubMed ID: 38531231
[TBL] [Abstract] [Full Text] [Related]
19. Distribution of Perigastric Station 4d Lymph Nodes in Vascularized Gastroepiploic Lymph Node Transfer: An Anatomic Study and Case Series.
Yoo H; Hong KY; Min S; Lee HS; Park DJ; Kim YS; Kong SH; Chang H
Ann Surg Oncol; 2024 Jun; 31(6):3694-3704. PubMed ID: 38530528
[TBL] [Abstract] [Full Text] [Related]
20. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study.
Chen X; Xu H; Chen X; Xu T; Tian Y; Wang D; Guo F; Wang K; Jin G; Li X; Wang R; Li F; Ding Y; Tang J; Fang Y; Zhao J; Liu L; Ma L; Meng L; Hou Z; Zheng R; Liu Y; Guan N; Zhang B; Tong S; Chen S; Li X; Shu Y
Signal Transduct Target Ther; 2024 Mar; 9(1):73. PubMed ID: 38528050
[TBL] [Abstract] [Full Text] [Related]
[Next]
